More Access and Evidence Articles

Access and Evidence

Hidden Answers: the Battle to Reveal Clinical Trial Results

Louise Kelly, (Jan 18, 2013)

Currently under no legal obligation to disclose all clinical trial results, pharmaceutical companies are now being pressured by volunteers to publish full investigation findings.
Access and Evidence

Take #2: Big Pharma Opt for New Strategy to Emerging Markets

Louise Kelly, (Jan 18, 2013)

The big pharmaceutical firms have been touting the opportunities in emerging markets as the cure to offset the slower growth in Western countries. But after paltry growth figures last year, the major drug manufacturers are reassessing their strategies.
Access and Evidence

Clinical Trials Worldwide Struggle to Find Participants

Ben Steele, (Jan 18, 2013)

New research has highlighted the continuing difficulty clinical trials are facing worldwide in the recruitment of participants.
Access and Evidence

India Plans Another Round of Compulsory Licenses

Ben Steele, (Jan 15, 2013)

India’s Department of Pharmaceuticals has begun the process of issuing compulsory licenses to three more drugs.
Access and Evidence

Pharma Wins Unpopularity Contest in 2012

Anonymous, (Jan 15, 2013)

A global patient-centric survey demonstrates that the overall reputation of the pharmaceutical industry declined in 2012 even if firms like Lundbeck, Gilead Sciences and Novartis came out on top.
Access and Evidence

European Guidelines for Evaluating Anticancer Medicines Updated

Lucy Brake, (Jan 14, 2013)

The European Medicines Agency has now finalised the revision of its guideline on the evaluation of anticancer medicinal products, which is due to come into effect in July 2013.
Access and Evidence

Pressure to Publish: A Campaign For Access to Trial Data

Zuzanna Fimińska, (Jan 14, 2013)

A public campaign, AllTrials, has been launched to influence governments, regulators and research bodies to ensure that all clinical trials, past and present, are registered and their full methods and results published.
Access and Evidence

Japan’s Health Ministry Loses Face

Louise Kelly, (Jan 11, 2013)

Despite extensive sympathetic press coverage, the Japanese government lost its appeal to uphold the ban of selling non-prescription drugs online in the nation’s Supreme Court today.
Access and Evidence

Pharma Giant Blows Whistle On Their Own Drug

Matthew Wood, (Jan 10, 2013)

Merck Sharp and Dohme, better known simply as Merck and Co., recently informed the European Medicine Agency that its medicine Tredaptive has distinct shortcomings, presenting the necessity for an extreme reevaluation.
Access and Evidence

Real World Evidence: Interview with Pfizer's Marc Berger

Anonymous, (Jan 10, 2013)

Rochelle speaks to Marc Berger about real world evidence, the potential collaborations, challenges and new predictive tools that it might bring.

Pages